We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVST icon
4126
Microvast
MVST
$306M
$347K ﹤0.01%
+42,248
New +$442K
PGEN icon
4127
Precigen
PGEN
$2.64B
$347K ﹤0.01%
69,620
-172,887
-71% -$995K
CSIQ icon
4128
CALL
Canadian Solar
CSIQ
$982M
$346K ﹤0.01%
10,000
-18,500
-65% -$704K
GSBC icon
4129
Great Southern Bancorp
GSBC
$857M
$346K ﹤0.01%
6,306
-2,240
-26% -$118K
UBX
4130
DELISTED
Unity Biotechnology
UBX
$346K ﹤0.01%
11,542
+6,032
+109% +$213K
EGBN icon
4131
Eagle Bancorp
EGBN
$847M
$345K ﹤0.01%
6,004
-660
-10% -$37K
ACET icon
4132
Adicet Bio
ACET
$84.1M
$344K ﹤0.01%
2,742
-1,760
-39% -$218K
AG icon
4133
CALL
First Majestic Silver
AG
$10.4B
$344K ﹤0.01%
+30,400
New +$392K
BYD icon
4134
Boyd Gaming
BYD
$5.9B
$343K ﹤0.01%
+5,424
New +$322K
MASI
4135
DELISTED
Masimo
MASI
$343K ﹤0.01%
+1,266
New +$343K
ONEW icon
4136
OneWater Marine
ONEW
$198M
$343K ﹤0.01%
8,522
-950
-10% -$39.9K
CCXI
4137
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
$342K ﹤0.01%
+20,000
New +$312K
TVRD
4138
Tvardi Therapeutics
TVRD
$24.4M
$341K ﹤0.01%
614
-2,448
-80% -$1.23M
MUDS
4139
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$341K ﹤0.01%
34,290
DCPH
4140
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$340K ﹤0.01%
10,000
CELC icon
4141
Celcuity
CELC
$4.5B
$339K ﹤0.01%
+18,859
New +$400K
TRML
4142
DELISTED
Tourmaline Bio
TRML
$339K ﹤0.01%
2,499
-1,405
-36% -$192K
MDLA
4143
CALL
DELISTED
Medallia, Inc.
MDLA
$339K ﹤0.01%
+10,000
New +$334K
BBAR icon
4144
BBVA Argentina
BBAR
$3.02B
$338K ﹤0.01%
+86,890
New +$307K
JHX icon
4145
James Hardie Industries
JHX
$17.7B
$337K ﹤0.01%
9,279
+161
+2% +$5.9K
CHS
4146
DELISTED
Chicos FAS, Inc.
CHS
$337K ﹤0.01%
75,166
-456,463
-86% -$2.61M
PKBO
4147
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$337K ﹤0.01%
+34,399
New +$334K
REPX icon
4148
Riley Exploration Permian
REPX
$829M
$336K ﹤0.01%
+14,329
New +$305K
ATHN.WS
4149
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$336K ﹤0.01%
246,979
+158,091
+178% +$213K
MNRL
4150
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$335K ﹤0.01%
17,483
+7,737
+79% +$149K

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.